Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
HERV-W envelope protein inhibits oligodendroglial precursor cell differentiation.
New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Development of the Brief Inventory of Perceived Stress.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
The International Symposium on the Multiple Sclerosis Brain
Editorial for JNV issue on PML.
First NW patient to receive OHSU/VAMC-invented MS drug
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Gilenya prescribing information

Pages